Plasmatic and phenotypic effects with alirocumab, a PCSK9...

Atherosclerosis 2017 / 08 Vol. 263

Plasmatic and phenotypic effects with alirocumab, a PCSK9 inhibitor, in familial hypercholesterolemia treatment (FH)

Simonelli, Francesca, Miotti, Cristiano, Filice, Barbara Fausta, Gallo, Giovanna, Burocchi, Simone, Presta, Vivanne, Salerno, Gerardo, Abbolito, Sofia, Volpe, Massimo, De Biase, Luciano
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
263
Language:
english
Journal:
Atherosclerosis
DOI:
10.1016/j.atherosclerosis.2017.06.800
Date:
August, 2017
File:
PDF, 134 KB
english, 2017
Conversion to is in progress
Conversion to is failed